• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[无可用内容]

[Not Available].

作者信息

Kuzmina N M, Maximov N I

机构信息

Izhevsk State Medical Academy.

出版信息

Kardiologiia. 2019 Jan 27;59(1):36-38. doi: 10.18087/cardio.2019.1.10223.

DOI:10.18087/cardio.2019.1.10223
PMID:30710987
Abstract

PURPOSE

to study adherence to therapy after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). We analyzed retrospectively 127 case histories of patients who underwent PCI for ACS in 2015 (in Udmurtia at that time PCIs were mostly carried out later than 6 hours after onset of symptoms).

INCLUSION CRITERIA

age 25-75 years; confirmed ACS; stenting of coronary arteries for the first time.

EXCLUSION CRITERIA

pregnancy; prisoners; incompetent persons; history of PCI or coronary artery bypass grafting. In two years after the PCI 95 patients were questioned concerning use of statins (including their doses) and dual antiplatelet therapy (DAPT).

RESULTS

In 2 years after index PCI 83% of patients took statins regularly. DAPT for 1 year or more after PCI received 85% of patients.

CONCLUSION

Adherence to therapy with statins and antiplatelet therapy was found to be high. PCI in patients with ACS was mainly delayed (more than 6 hours from the onset of symptoms). It is necessary to further improve the routing of patients to PCI performing centers from Udmurtia regions for the timely myocardial revascularization.

摘要

目的

研究急性冠状动脉综合征(ACS)患者经皮冠状动脉介入治疗(PCI)后的治疗依从性。我们回顾性分析了2015年接受ACS-PCI治疗的127例患者的病历(当时在乌德穆尔特共和国,PCI大多在症状发作后6小时以上进行)。

纳入标准

年龄25 - 75岁;确诊为ACS;首次进行冠状动脉支架置入术。

排除标准

妊娠;囚犯;无行为能力者;有PCI或冠状动脉旁路移植术病史。PCI术后两年,对95例患者进行了关于他汀类药物使用情况(包括剂量)和双联抗血小板治疗(DAPT)的询问。

结果

在首次PCI术后两年,83%的患者规律服用他汀类药物。85%的患者PCI术后接受了1年或更长时间的DAPT治疗。

结论

他汀类药物和抗血小板治疗的依从性较高。ACS患者的PCI治疗主要存在延迟(症状发作后超过6小时)。有必要进一步改善从乌德穆尔特地区将患者转运至PCI实施中心的流程,以便及时进行心肌血运重建。

相似文献

1
[Not Available].[无可用内容]
Kardiologiia. 2019 Jan 27;59(1):36-38. doi: 10.18087/cardio.2019.1.10223.
2
Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.冠状动脉支架置入术后双联抗血小板治疗延长超过12个月的急性冠状动脉综合征患者的长期预后
Catheter Cardiovasc Interv. 2017 Jun 1;89(7):1176-1184. doi: 10.1002/ccd.26831. Epub 2016 Nov 10.
3
Initiation and duration of dual antiplatelet therapy after inpatient percutaneous coronary intervention with stent implantation in Germany: An electronic healthcare database cohort study.德国住院患者经皮冠状动脉介入治疗并植入支架后双联抗血小板治疗的起始与持续时间:一项电子医疗数据库队列研究
Z Evid Fortbild Qual Gesundhwes. 2017 Feb;120:31-38. doi: 10.1016/j.zefq.2016.12.007. Epub 2017 Feb 7.
4
Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.替罗非班辅助经皮冠状动脉介入治疗患者术前双联抗血小板治疗对围术期心肌梗死的影响。
Thromb Res. 2018 Apr;164:17-23. doi: 10.1016/j.thromres.2018.02.008. Epub 2018 Feb 15.
5
Current management and quality of life of patients with acute coronary syndrome undergoing percutaneous coronary intervention in Greece: 12-Month results from antiplatelet therapy observational study II (APTOR II).希腊经皮冠状动脉介入治疗的急性冠状动脉综合征患者的现状管理和生活质量:抗血小板治疗观察性研究 II(APTOR II)的 12 个月结果。
Hellenic J Cardiol. 2013 Jul-Aug;54(4):255-63.
6
Dual Antiplatelet Therapy Guided by CYP2C19 Polymorphisms after Implantation of Second-Generation Drug-Eluting Stents for Management of Acute Coronary Syndrome.第二代药物洗脱支架植入后基于CYP2C19基因多态性指导的双联抗血小板治疗用于急性冠状动脉综合征的管理
Int Heart J. 2018 Jan 27;59(1):21-26. doi: 10.1536/ihj.17-005. Epub 2017 Dec 27.
7
Recurrent acute coronary syndrome and restenosis after percutaneous coronary intervention in a patient with idiopathic thrombocytopenic purpura: a case report and literature review.一名特发性血小板减少性紫癜患者经皮冠状动脉介入治疗后复发性急性冠状动脉综合征和再狭窄:病例报告及文献综述
BMC Cardiovasc Disord. 2015 Sep 18;15:101. doi: 10.1186/s12872-015-0092-3.
8
A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial.一项关于接受经皮冠状动脉介入治疗(PCI)的急性冠状动脉综合征(ACS)患者血小板功能引导下抗血小板治疗降阶梯的随机试验。急性冠状动脉综合征慢性抗血小板治疗中血小板抑制反应性测试(TROPICAL-ACS)试验的原理与设计。
Thromb Haemost. 2017 Jan 5;117(1):188-195. doi: 10.1160/TH16-07-0557. Epub 2016 Sep 22.
9
Predictors and Management of Antiplatelet-Related Bleeding Complications for Acute Coronary Syndrome in Chinese Elderly Patients.中国老年急性冠状动脉综合征患者抗血小板相关出血并发症的预测因素及管理
Cell Physiol Biochem. 2018;50(3):1164-1177. doi: 10.1159/000494543. Epub 2018 Oct 24.
10
[Meta-analysis on safety and efficacy of dual antiplatelet therapy combining with proton pump inhibitors for patients after percutaneous coronary intervention].经皮冠状动脉介入治疗术后患者双联抗血小板治疗联合质子泵抑制剂安全性和有效性的Meta分析
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Feb 24;47(2):129-140. doi: 10.3760/cma.j.issn.0253-3758.2019.02.010.